Michael Hyun-ook Kim, MD, MMM

Department

Medicine

Position

Professor

Articles

• Expert Review Pharmacoeconomics Outcomes Research
  Sr, Healthcare resource utilization in patients with newly diagnosed atrial fibrillation in the United States, p. 1-9 2022
• J American Heart Association
  Sr, US Antiarrhythmic drug treatment for patients with atrial fibrillation: an insurance claims-based approach.
  10, p. e016792 2021
• Sr Care Pharm
  Practical Insights into Anticoagulation for an Aging Population
  35, p. 150 2020
• Advances in Therapy
  First, Patient Diversity and Population Health-Related Cardiovascular Outcomes Associated with Warfarin Use in Atrial Fibrillation: an analysis using Administrative Claims Data
  35 (11), p. 1-122069-2080 2018
• Journal of the American College of Cardiology:Clinical Electrophysiology
  First, Hospitalization and costs in primary prevention ICD recipients: who determines the outcomes?
  4 (2), p. 254-256 2018
• Advances in Therapy
  Impact of warfarin on atrial fibrillation outcomes related to economic consumption patterns:  hospitalization, cost, and mortality may be predictable and modifiable at the population level
  33 (9), p. 1579-1599 2016
• Journal of Innovations in Cardiac Rhythm Management
  Patterns of dofetilide use for the treatment of atrial fibrillation
  7, p. 2425-2428 2016
• Journal of Managed Care & Specialty Pharmacy
  , A call for appropriate evidence and outcomes-based use and measurement of anticoagulation for atrial fibrillation: moving the population towards improved health via multiple stakeholders
  21 (11), p. 1034-1038 2015
• Heart Rhythm Case Reports
  A case series of anomalous high pacing lead impedances in normally functioning leads
  1 (6), p. 449-452 2015
• Heart Rhythm
  Time course of appropriate implantable cardioverter-defibrillator therapy and implications for guideline-based driving restrictions
  12 (8), p. 1728-1736 2015
• Journal of the American College of Cardiology
  Shared risk factors for anticoagulation in nonvalvular atrial fibrillation:  a dilemma in clinical decision making
  63 (20), p. 2148-2150 2014
• Journal of Managed Care Pharmacy
  , Health care burden of dyspepsia among nonvalvular atrial fibrillation patients
  20 (4), p. 391-399 2014
• Advances in Therapy
  Impact of dronedarone treatment on healthcare resource utilization in patients with atrial fibrillation/flutter
  31 (3), p. 318-332 2014
• International Journal of Clinical Cardiology
  Cardiac troponin assessment following atrial fibrillation ablation: implications for chest pain evaluation
  1 (2) 2014
• Journal of Interventional Cardiac Electrophysiology
  The relationship between defibrillation threshold and total mortality
  38 (3), p. 203-208 2013
• Journal of Interventional Cardiac Electrophysiology
  Prospective evaluation of cinefluoroscopy and chest radiography for Riata lead defects: implications for future lead screening
  38 (2), p. 131-135 2013
• Journal of Interventional Cardiac Electrophysiology
  Effectiveness of VF induction with DC Fibber versus conventional induction methods in patients on chronic amiodarone therapy
  38 (2), p. 137-141 2013
• Heart Rhythm
  Device advisory letters:  readability and comprehension, patient-centered outcomes not to be "misunderstood"
  10 (4), p. 508-509 2013
• Journal of the American College of Cardiology
  Treatment targets in atrial fibrillation:  "is feeling better good enough?"
  61, p. 461-462 2013
• Journal of Cardiovascular Electrophysiology
  Prevalence and predictors of cable extrusion and loss of electrical integrity with the Riata defibrillator lead
  23 (11), p. 1207-1212 2012
• Journal of Cardiovascular Electrophysiology
  Catheter ablation of atrial fibrillation in Octogenarians:  the Right "medicine?"
  23 (7), p. 694-696 2012
• Expert Review of Clinical Pharmacology
  Do the benefits of anti-arrhythmic drugs outweigh the associated risks? A tale of treatment goals in atrial fibrillation
  5 (2), p. 163-171 2012
• Journal of Innovations in Cardiac Rhythm Management
  Concepts in disease progression of atrial fibrillation and implications for medical management
  3, p. 697-712 2012
• Journal of Cardiovascular Electrophysiology
  Long-term insertable loop monitors:  how much should we watch to get an answer (diagnosis)?
  23 (1), p. 72-73 2012
• Clinical Therapeutics
  One-year treatment persistence and potential adverse events among patients with atrial fibrillation treated with amiodarone or sotalol: a retrospective claims database analysis
  33 (11), p. 1668-1681 2011
• Circulation: Cardiovascular Quality and Outcomes
  Estimation of total incremental health care costs in patients with atrial fibrillation in the United States
  4 (3), p. 313-320 2011
• Heart Rhythm
  A prospective, randomized comparison of the acute hemodynamic effects of biventricular and left ventricular pacing with cardiac resynchronization therapy
  8 (5), p. 685-691 2011
• Journal of Cardiovascular Electrophysiology
  Predicting the risk of heart failure events and subsequent mortality:  what doth the seer know?
  21 (11), p. 1224-1225 2010
• Advances in Therapy
  Total costs and atrial fibrillation ablation success or failure in Medicare-aged patients in the United States
  27 (9), p. 600-612 2010
• Journal of Interventional Cardiac Electrophysiology
  The impact of stored atrial rhythm diagnostics in permanent pacemakers and the management of atrial fibrillation:  the Vitatron Selection AFm Registry Study
  28 (3), p. 227-234 2010
• Pacing and Clinical Electrophysiology
  Predictors of early mortality in patients age 80 and older receiving implantable defibrillators
  33 (8), p. 981-987 2010
• Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
  Patterns and predictors of discontinuation of rhythm control drug therapy in patients with newly diagnosed atrial fibrillation
  29 (12), p. 1417-1426 2009
• Current Medical Research and Opinion
  Incidence and economic burden of suspected adverse events and adverse event monitoring during AF therapy
  25 (12), p. 3037-3047 2009
• Advances in Therapy
  Cost of atrial fibrillation in United States managed care organizations
  26 (9), p. 847 2009
• Journal of Cardiovascular Electrophysiology
  Acute hemodynamic effects of atrial pacing with cardiac resynchronization therapy
  20 (8), p. 894-900 2009
• Advances in Therapy
  National assessment of Medicare prescription plan coverage gaps among patients with atrial fibrillation in the US
  26 (8), p. 784-794 2009
• Journal of Cardiovascular Electrophysiology
  A novel method for sinus node modification and phrenic nerve protection in resistant cases
  20 (6), p. 689-691 2009
• Current Medical Research and Opinion
  Incidence and temporal pattern of hospital readmissions for patients with atrial fibrillation
  25 (5), p. 1215-1220 2009
• Annals of Pharmacotherapy
  Cost of hospital admission for antiarrhythmic drug initiation in atrial fibrillation
  43 (5), p. 840-848 2009
• Journal of Electrocardiology
  Influence of structural heart disease on characteristics of atrial fibrillation recurrence in patients with dual chamber pacemakers
  42 (2), p. 128-135 2009
• Journal of cardiovascular nursing
  A written policy increases compliance with guidelines for therapeutic anticoagulation prior to elective direct current cardioversion of atrial fibrillation
  22 (5), p. 417-421 2007
• Journal of Cardiovascular Electrophysiology
  A prospective comparison of AV delay programming methods for hemodynamic optimization during cardiac resynchronization therapy
  18 (5), p. 490-496 2007
• Pacing and Clinical Electrophysiology
  Value of pacemaker atrial diagnostic data in patients with paroxysmal atrial fibrillation:  an opportunity to improve rates of warfarin utilization
  30 (4), p. 580-583 2007
• Occupational and Environmental Medicine
  Association of ventricular arrhythmias detected by implantable cardioverter defibrillator and ambient air polllutants in the St. Louis, Missouri metropolitan area
  63 (9), p. 591-596 2006
• Heart Rhythm
  Left bundle branch block during orthodromic reciprocating tachycardia:  where is the accessory pathway?
  3 (5), p. 610-611 2006
• Journal of Heart and Lung Transplantation
  Cardiac resynchronization therapy:  a potential option for congenitally corrected transposition of the great vessels
  24 (12), p. 2293-2296 2005
• Pacing and Clinical Electrophysiology
  Polymorphic ventricular tachycardia with a normal QT interval following azithromycin
  28 (11), p. 1221-1222 2005
• Annals of Internal Medicine
  Amiodarone prophylaxis reduces major cardiovascular morbidity and length of stay after cardiac surgery:  a meta-analysis
  143 (5), p. 327-336 2005
• Archives of Internal Medicine
  Occurrence and characteristics of stroke events in the Atrial Fibrillation Follow-up Investigation of Sinus Rhythm Management (AFFIRM) study
  165 (10), p. 1185-1191 2005
• The Lancet
  Cardiac pacing:  the state of the art
  364, p. 1701-1719 2004
• Cardiac Electrophysiology Review
  Low molecular weight heparin in atrial fibrillation management:  facts, fiction, future
  7 (4), p. 397-400 2003
• Journal of Interventional Cardiac Electrophysiology
  Diagnostic value of single versus dual chamber electrograms recorded from an implantable defibrillator
  9 (1), p. 49-53 2003
• Journal of the American College of Cardiology
  Maintenance of sinus rhythm in patients with atrial fibrillation:  an AFFIRM substudy of the first antiarrhythmic drug.
  42 (1), p. 20-29 2003
• American Heart Journal
  Use patterns of low molecular weight heparin and the impact on length of stay in patients hospitalized for atrial fibrillation
  145 (4), p. 665-669 2003
• Annals of Emergency Medicine
  A prospective, randomized, controlled trial of an emergency department-based atrial fibrillation treatment strategy with low molecular weight heparin
  40 (2), p. 187-192 2002
• Pacing and Clinical Electrophysiology
  The immediate reproducibility of T wave alternans during bicycle exercise
  25 (8), p. 1185-1191 2002
• American Journal of Cardiology
  Effect of amiodarone +/- diltiazem +/- beta-blocker on frequency of atrial fibrillation, length of hospitalization, and hospital costs after coronary artery bypass grafting
  89 (9), p. 1126-1128 2002
• International Journal of Cardiology
  Atrial fibrillation after coronary surgery:  comparison between different health care systems
  82 (3), p. 209-218 2002
• Journal of Cardiovascular Electrophysiology
  Kearns-Sayre Syndrome:  association with Long QT syndrome?
  13 (2), p. 184-185 2002
• Cardiology Review
  Importance of limiting atrial fibrillation after heart surgery
  19 (1), p. 19-23 2002
• American Journal of Cardiology
  Time course and frequency of subtherapeutic anticoagulation for newly prescribed warfarin anticoagulation before elective cardioversion of atrial fibrillation or flutter
  88 (12), p. 1428-1431 2001
• American Journal of Cardiology
  Clinical outcomes and costs associated with a first episode of uncomplicated atrial fibrillation presenting to the emergency room
  88 (1), p. 74-76 2001
• American Heart Journal
  Prevalence of central venous occlusion in patients with chronic defibrillator leads
  141 (5), p. 813-816 2001
• American Heart Journal
  Postoperative atrial fibrillation after heart surgery:  what are the goals of prevention?
  141 (5), p. 691-693 2001
• American Journal of Cardiology
  Effect of postoperative atrial fibrillation on length of stay after cardiac surgery (the postoperative atrial fibrillation in cardiac surgery study (PACS2)
  87 (7), p. 881-885 2001
• Journal of Cardiovascular Electrophysiology
  Electrogram polarity and cavotricuspid isthmus block during ablation of typical atrial flutter
  12 (4), p. 393-399 2001
• International Journal of Cardiology
  Cardiac risk assessment in noncardiac thoracic surgery
  13 (2), p. 137-146 2001
• American Journal of Cardiology
  Complete atrioventricular block after valvular heart surgery and the timing of pacemaker implantation
  87 (5), p. 649-651 2001
• Congestive Heart Failure
  Diastolic dysfunction in the presence of left ventricular systolic dysfunction: implications of beta-adrenergic blocking therapy
  7 (2), p. 71-76 2001
• Cardiovascular Reviews and Reports
  Pharmacologic and nonpharmacologic approaches to the prevention of atrial fibrillation after heart surgery
  22 (5), p. 292-296 2001
• Journal of Cardiovascular Pharmacology and Therapeutics
  Cost analysis of transthoracic cardioversion of atrial fibrillation with and without ibutilide pretreatment
  5 (4), p. 259-266 2000
• Circulation
  Effects of digoxin on acute, atrial fibrillaton-induced changes in atrial refractoriness
  102 (20), p. 2503-2508 2000
• Journal of the American College of Cardiology
  Diagnostic value of tachycardia features and pacing maneuvers during paroxsymal supraventricular tachycardia
  36 (2), p. 574-582 2000
• Journal of Cardiovascular Electrophysiology
  Effect of chronic amiodarone therapy on defibrillation energy requirements in humans
  11 (7), p. 736-740 2000
• Journal of Cardiovascular Electrophysiology
  Prevalence and significance of exit block during arrhythmias arising in pulmonary veins
  11 (4), p. 379-386 2000
• Journal of Cardiovascular Electrophysiology
  Comparison of endocardial activation times at effective and ineffective ablation sites within pulmonary veins
  11 (2), p. 155-159 2000
• American Journal of Cardiology
  Outcome of men with ischemic cardiomyopathy, asymptomatic nonsustained ventricular tachycardia, and negative electrophysiology studies
  85 (1), p. 119-121 2000
• American Journal of Cardiology
  Electrocardiographic predictors of successful ablation of tachycardia or bigeminy arising in the right ventricular outflow tract
  84 (10), p. 1266-1268 1999
• Circulation
  Bayesian persuasion
  100 (16), p. e68-e72 1999
• Circulation
  Effects of beta-adrenergic blocking therapy on left ventricular diastolic relaxation properties in patients with dilated cardiomyopathy
  100 (7), p. 729-735 1999
• American Journal of Cardiology
  Effect of electrode polarity on the energy required for transthoracic atrial defibrillation
  84 (2), p. 228-230 1999
• Journal of Cardiovascular Electrophysiology
  Target temperatures of 48 degrees celsius versus 60 degrees celsius during slow pathway ablation:  a randomized comparison
  10 (6), p. 799-803 1999
• Circulation
  Sudden death in a 55-year-old woman with systemic lupus erythematosus
  98 (3), p. 271-275 1998
• Clinical Cardiology
  Silent ischemic cardiomyopathy and left coronary ostial stenosis secondary to radiation therapy
  19 (7), p. 602 1996

Publications

• Circulation: Cardiovascular Quality and Outcomes
  Senior, Impact of health related social needs on sex-based differences in hospital readmissions for atrial fibrillation
  15.suppl_1, p. A68 2022
• J American College of Cardiology
  Sr, Regularization of ventricular activation during atrial fibrillation using para-hisian and ventricular pacing
  79, Issue 9, Suppl A, p. 93 2022
• J American College of Cardiology
  Sr, Relationship of social determinants of health and hospitalizations for atrial fibrillation: a nationwide readmissions database study
  79, Issue 9, Suppl_1, p. 11-11 2022
• Circulation
  Sr, Outcomes of radiofrequency transcatheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy: a systematic review and meta-analysis
  144, p. A14052 2021
• J American College of Cardiology
  Sr, Total 30-day mortality in medicare beneficiaries following catheter ablation for atrial fibrillation (2016 -2017)
  77, p. 231 2021
• Circulation
  Sr, Sex-related differences in health care utilization in patients with atrial flutter 2020
• Circulation: Cardiovascular Quality and Outcomes
  Sr, Population-level insights into 30-day mortality in medicare beneficiaries after inpatient and outpatient catheter ablation for atrial fibrillation
  13 (Suppl_1), p. A341 2020
• J Am Coll Cardiol
  Sr, Delayed versus Early Cardioversion for Patients with Uncomplicated Atrial Fibrillation Meta-Analysis
  75 (11), p. 420 2020
• J American College of Cardiology
  Sr, National economic cost burden of atrial flutter only patients without atrial fibrillation.
  73 (Supplement 1), p. 329 2019
• J Am Coll Cardiol
  Sr, Comparative variation in health care resource utilization between patients with atrial flutter only versus atrial fibrillation with or without atrial flutter.
  73 (Supplement 1), p. 332 2019

Presentations

• Impact of health related social needs on sex-based differences in hospital readmissions for atrial fibrillation. Poster at the Annual Scientific Sessions for Cardiovascular Quality and Outcomes Research 2022
• Regularization of ventricular activation during atrial fibrillation using para-hisian and ventricular pacing. Poster presentation at the ACC Scientifc Sessions, Washington DC 2022
• Relationship of social determinants of health and hospitalizations for atrial fibrillation: a nationwide readmissions database study. Moderated Poster at ACC Scientifc Sessions, Washington DC. 2022
• Left ventricular lead placement using non-occlusive venogram for cardiac resynchronization therapy: a pilot study. Poster at 53rd Annual Midwest Student Biomedical Research Forum, Omaha, NE 2022
• Predictors of atrial fibrillation free survival in patients with implantable cardiac devices. Global Health Conference Midwest, Omaha, NE 2022
• Outcomes of Radiofrequency Transcatheter Ablation of Atrial Fibrillation in Patients with Hypertrophic Cardiomyopathy: A Systematic Review and Meta-Analysis 2021
• Effect of post-procedural phone calls by Electrophysiology nurses on unplanned urgent care or emergency room visits after cardiac electrophysiology procedures. Poster at the ACC Annual Quality Summit 2021
• Andukuri V, Xu L, Puckrein G, Walters R, Kim MH. Total 30-day mortality in medicare beneficiaries following catheter ablation for atrial fibrillation (2016 - 2017). 2021: JACC 77 (18_Suppl 1_), 231. Presented at American College of Cardiology Annual Scientific Sessions. 2021
• Kim K, Kim S, Kim MH. Sex-related differences in health care utilization in patients with atrial flutter. Circulation 2020; 142 (Suppl_3), A12593. Presented at Annual Scientific Session of the American Heart Association. 2020
• Andukuri V, Xu L, Puckrein GA, Walters RW, Kim MH.  Population-level insights into 30-day mortality in Medicare beneficiaries after inpatient and outpatient catheter ablation for atrial fibrillation.  Virtual Abstract Poster Session at AHA Quality of Care and Outcomes Scientific Sessions. 2020
• American College of Cardiology Scientific Sessions Poster Presentation (Virtual): Delayed versus Early Cardioversion for Patients with Uncomplicated Atrial Fibrillation Meta-Analysis 2020
• Internal Medicine Grand Rounds:  Do We Really Know Atrial Flutter: Clinical and Epidemiological Perspectives 2020
• American College of Cardiology Scientific Sessions Abstract Presentation (Poster): National Economic Cost Burden of Atrial Flutter Only Patients Without Atrial Fibrillation; New Orleans, LA 2019
• American College of Cardiology Scientific Sessions Abstract Presentation (Poster): Comparative Variation in Health Care Resource Utilization Between Patients With Atrial Flutter Only Versus Atrial Fibrillation With Or Without Atrial Flutter; New Orleans, LA 2019
• Invited Lecture:  Cardiovascular Outcomes and Atrial Fibrillation; Maricopa Medical Center; Phoenix, AZ 2019

Awards

• Remarkable Reviewer Award 2021
  For work on the Heart Rhythm Journal in 2020
  Heart Rhythm Society
• Remarkable Reviewer Award 2018
  Heart Rhythm Journal
• Remarkable Reviewer Award 2017
  For work in 2016
  Heart Rhythm Journal
• Elite/Top Reviewer Award: 2014, 2015, and 2016
  Awarded only to 10 or less Journal Reviewers
  Journal of the American College of Cardiology
• Top Grade/Best Reviewers Designation, 2012
  Annals of Internal Medicine
• NASPE Traveling Fellowship
  North American Society of Pacing and Electrophysiology
• Midwest Trainee Investigator Award
  Central Society for Clinical Research